Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $18,985 - $21,080
298 Added 6.76%
4,705 $300,000
Q1 2023

Apr 27, 2023

BUY
$65.71 - $74.53 $59,861 - $67,896
911 Added 26.06%
4,407 $305,000
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $239,406 - $283,490
3,496 New
3,496 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hartford Funds Management CO LLC Portfolio

Follow Hartford Funds Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Funds Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Funds Management CO LLC with notifications on news.